$DUET
DUET Acquisition Corp Stock $duet

$duet Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000149315223010120 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$190.2K	$191.7K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$280.6K	$1.289M
YoY Change		84694.08%
Operating Profit		-$1.289M
YoY Change
Interest Expense	$436.1K	$1.048M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$155.5K	-$240.5K
YoY Change		15719.87%
Income Tax	$229.1K	$229.1K
% Of Pretax Income	147.29%
Net Earnings	-$73.56K	-$469.6K
YoY Change		30792.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$0.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.07K	$27.07K
YoY Change		8.28%
Cash & Equivalents	$27.07K		$25.00K
Short-Term Investments	$88.59M
Other Short-Term Assets	$0.00	$0.00
YoY Change		-100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$27.07K	$27.07K	$215.5K
YoY Change	-87.44%	-87.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$88.59M	$88.59M
YoY Change
Total Long-Term Assets	$88.59M	$88.59M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$27.07K	$27.07K	$215.5K
Total Long-Term Assets	$88.59M	$88.59M	$0.00
Total Assets	$88.62M	$88.62M	$215.5K
YoY Change	41026.81%	41026.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$182.5K	$182.5K
YoY Change		11907.89%
Accrued Expenses	$25.00K	$25.00K	$1.523K
YoY Change	1541.5%
Deferred Revenue
YoY Change
Short-Term Debt	$100.0K	$100.0K
YoY Change		-47.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$726.8K	$726.8K	$192.0K
YoY Change	278.55%	278.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.588M	$2.588M
YoY Change
Total Long-Term Liabilities	$2.588M	$2.588M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$726.8K	$726.8K	$192.0K
Total Long-Term Liabilities	$2.588M	$2.588M
Total Liabilities	$3.314M	$3.314M	$192.0K
YoY Change	1626.2%	1626.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.239M		-$1.523K
YoY Change	146920.03%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.239M	$85.30M	$23.48K
YoY Change
Total Liabilities & Shareholders Equity	$88.62M	$88.62M	$215.5K
YoY Change	41026.81%	41026.43%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$73.56K	-$469.6K
YoY Change		30792.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$50.10K	-$892.7K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$87.57M
YoY Change
Cash From Investing Activities	$0.00	-$87.57M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K	$88.47M
YoY Change		353766.15%
NET CHANGE
Cash From Operating Activities	-50.10K	-$892.7K
Cash From Investing Activities	0.000	-$87.57M
Cash From Financing Activities	50.00K	$88.47M
Net Change In Cash	-100.0	$2.066K
YoY Change		-91.74%
FREE CASH FLOW
Cash From Operating Activities	-$50.10K	-$892.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001890671
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent		usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2021Q4	DUET	Franchise Tax Payable FranchiseTaxPayable		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	DUET	Working Capital Loan WorkingCapitalLoan		usd
CY2021Q4	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	DUET	Franchise Tax Expenses FranchiseTaxExpenses		usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	DUET	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
	DUET	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	DUET	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan		usd
CY2022	DUET	Collection Of Subscription Receivable CollectionOfSubscriptionReceivable		usd
	DUET	Collection Of Subscription Receivable CollectionOfSubscriptionReceivable		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	DUET	Non Cash Deferred Underwriting Fee Payable NonCashDeferredUnderwritingFeePayable		usd
	DUET	Non Cash Initial Classification Of Class A Ordinary Shares Subject To Redemption NonCashInitialClassificationOfClassAOrdinarySharesSubjectToRedemption		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2022	DUET	Deferred Offering Costs Paid For By Promissory Note Related Party DeferredOfferingCostsPaidForByPromissoryNoteRelatedParty		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41237
CY2022	dei	Entity Registrant Name EntityRegistrantName	DUET ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2744116
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	V03-11-02, Designer Office
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	V03, Lingkaran SV
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Sunway Velocity
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2022	dei	Entity Address Country EntityAddressCountry	MY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55100
CY2022	dei	City Area Code CityAreaCode	60-3
CY2022	dei	Local Phone Number LocalPhoneNumber	9201-1087
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	85200000	usd
CY2022	dei	Auditor Firm AuditorFirmId	3686
CY2022	dei	Auditor Name AuditorName	Adeptus Partners, LLC
CY2022	dei	Auditor Location AuditorLocation	Ocean, New Jersey
CY2022Q4	us-gaap	Cash Cash	27066	usd
CY2021Q4	us-gaap	Cash Cash	25000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	190478	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	27066	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	215478	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	88592161	usd
CY2022Q4	us-gaap	Assets Assets	88619227	usd
CY2021Q4	us-gaap	Assets Assets	215478	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1523	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182520	usd
CY2022Q4	DUET	Franchise Tax Payable FranchiseTaxPayable	190207	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	229101	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	190478	usd
CY2022Q4	DUET	Working Capital Loan WorkingCapitalLoan	100000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	726828	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	192001	usd
CY2022Q4	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission	2587500	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3314328	usd
CY2021Q4	us-gaap	Liabilities Liabilities	192001	usd
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	8625000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	8625000	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24784	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2239115	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1523	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23477	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88619227	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	215478	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1097191	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1523	usd
CY2022	DUET	Franchise Tax Expenses FranchiseTaxExpenses	191682	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1288873	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1523	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1048411	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-240462	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1523	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	229101	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-469563	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1523	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23477	usd
CY2022	DUET	Stock Issued During Period Value Sale Of Units In Initial Public Offering StockIssuedDuringPeriodValueSaleOfUnitsInInitialPublicOffering	86250000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-87543750	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3900000	usd
CY2022	DUET	Stock Issued During Period Value Representative Share StockIssuedDuringPeriodValueRepresentativeShare	862500	usd
CY2022	DUET	Adjustments To Additional Paid In Capital Offering And Underwriting Costs AdjustmentsToAdditionalPaidInCapitalOfferingAndUnderwritingCosts	-2674015	usd
CY2022	DUET	Adjustments To Additional Paid In Capital Deferred Underwriting Commission AdjustmentsToAdditionalPaidInCapitalDeferredUnderwritingCommission	-2587500	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-469563	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1523	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1523	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23477	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23477	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-469563	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1523	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1048411	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	180997	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1523	usd
CY2022	DUET	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	25000	usd
CY2022	DUET	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-190207	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	229101	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-892669	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	87571802	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87571802	usd
CY2022	DUET	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan	100000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	84660072	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3900000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	193535	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	88466537	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2066	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27066	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2022	DUET	Non Cash Deferred Underwriting Fee Payable NonCashDeferredUnderwritingFeePayable	2587500	usd
CY2022	DUET	Non Cash Initial Classification Of Class A Ordinary Shares Subject To Redemption NonCashInitialClassificationOfClassAOrdinarySharesSubjectToRedemption	87543750	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3057	usd
	DUET	Deferred Offering Costs Paid For By Promissory Note Related Party DeferredOfferingCostsPaidForByPromissoryNoteRelatedParty	190478	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zKp7gIm28q83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_82F_zOtqtaFd16e7">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DUET Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on September 20, 2021. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had not commenced any operations. All activity for the period from September 20, 2021 (inception) through December 31, 2022, relates to the Company’s formation, its initial public offering, and its entry into a business combination agreement and plan of merger, as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sponsor is DUET Partners LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on January 19, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2022, the Company consummated its Initial Public Offering of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJhGlhOxUM3a" title="Number of stock units issued">7,500,000</span> units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCXZR4HNXZd7" title="Number of units issued, at par value">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqc46QLrC9n7" title="Proceeds from initial public offering">75,000,000</span>, and incurring offering costs of $<span style="background-color: white"><span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zKDWeD19Muei" title="Incurring offering costs">5,161,516</span></span>, of which $<span id="xdx_90B_eus-gaap--DeferredOfferingCosts_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5tneBwPkwY5" title="Deferred offering costs">2,250,500</span> was for deferred underwriting commissions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zd5czeIYelZ6" title="Number of stock units issued">356,250</span> units (the “Private Placement Units”) to DUET Partners LLC, the sponsor of the Company (the “Sponsor”), at a price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zXkzKMY0ZqLl" title="Number of units issued, at par value">10.00</span> per Private Placement Unit, generating total gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zRfqMZPzK8oh" title="Proceeds from private placement">3,562,500</span> (the “Private Placement”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequently, on January 24, 2022, the Company consummated the closing of the sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124_zCAVBcRmIiMf" title="Number of stock units issued">1,125,000</span> additional units at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20220124_zyDHEpikEwH8" title="Number of units issued, at par value">10.00</span> per Unit upon receiving notice of the underwriters’ election to fully exercise their overallotment option (“Overallotment Units”), generating additional gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124_znqzjFfs58b6" title="Proceeds from sale of units, net of IPO costs">11,250,000</span> and incurred additional offering costs of $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124_zS88wTNQM5W1" title="Incurring offering costs">506,250</span>, of which $<span id="xdx_90B_eus-gaap--DeferredOfferingCosts_iI_c20220124_z4F5EFYyK2Fj" title="Deferred offering costs">337,500</span> are for deferred underwriting commissions. Each Unit, including the Overallotment Units, consists of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dc_c20220123__20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5Od85SWm9p3" title="Number of common stock issued">one</span> share of Class A common stock of the Company, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziaBinj2TFpd" title="Common stock, par value">0.0001</span> per share (“Class A Common Stock”), and <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_dc_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zc2SskkajVlk" title="Number of warrant issued">one</span> redeemable warrant of the Company (“Warrant”), with each Warrant entitling the holder thereof to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_dc_c20220123__20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDablZJErmGa" title="Number of common stock issued">one</span> share of Class A Common Stock for $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z0MAdllHzCrd" title="Shares issued, per share">11.50</span> per share, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-261494).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zC8xzFC9PvTa" title="Number of stock units issued">33,750</span> Private Placement Units to DUET Partners LLC, a Delaware limited liability company (the “Sponsor”), generating additional gross proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zJTvI9FNXLyf" title="Proceeds from sale of private placement units">337,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A total of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220123__20220124_z1NhEvAtmf97" title="Proceeds from offering and private placements">87,543,750</span>, comprised of the proceeds from the Offering and the proceeds of private placements that closed on January 20, 2022 and January 24, 2022, net of the underwriting commissions, discounts, and offering expenses, was deposited in a trust account (“Trust Account”) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction costs of the Initial Public Offering with the exercise of the overallotment amounted to $<span id="xdx_901_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpSzbxcw6Fh3" title="Incurring offering costs">5,667,766</span> consisting of $<span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zqrrWdRm1UAg" title="Cash underwriting fees">1,293,750</span> of cash underwriting fees, $<span id="xdx_903_ecustom--DeferredUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zdWpBbW5a1Ad" title="Deferred underwriting fees">2,587,500</span> of deferred underwriting fees and $<span id="xdx_90D_ecustom--OtherCostsInExerciseOfOverallotment_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFfCgQcpnZhh" title="Other costs">492,766</span> of other costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Initial Public Offering $<span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znzqBJBeL4El" title="Cash held in trust account">818,211</span> of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, we have available to us $<span id="xdx_90E_eus-gaap--Cash_iI_c20221231_zSZrL6hIG85e" title="Cash">27,066</span> of cash on our balance sheet and a working capital deficit of $<span id="xdx_90B_ecustom--WorkingCapital_iI_c20221231_ziu9aerfEThi" title="Working capital">190,081</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20221231__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember__srt--RangeAxis__srt--MinimumMember_znCccPae83Gl" title="Business acquistion, ownership interest percentage">80</span>% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires <span id="xdx_905_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20221231__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember_znOeLUuELa3k" title="Business acquistion, ownership interest percentage">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 25, 2022, the Company entered into a definitive business combination agreement and plan of merger (the “Merger Agreement”) with Millymont Limited, a private limited company incorporated in Ireland (“Holdco”), Duet Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Holdco (“Merger Sub”), J. Streicher Technical Services, LLC, a Delaware limited liability company (“J. Streicher”), Anteco Systems, S.L., trading as AnyTech365, a company incorporated in Spain and registered at the Commercial Registry of Malaga under reference MA-122108 (the “Target”), Miguel Ángel Casales Ruiz and Thomas Marco Balsloev, as the sellers’ representatives (the “Sellers’ Representatives”) and Lee Keat Hin, as the Company’s representative (the “Company Representative”). Pursuant to the Merger Agreement, the parties will effect the merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity and a wholly-owned subsidiary of Holdco, as a result of which (a) the Company will issue shares of Class A Common Stock to Holdco, with such amount of shares to be determined in accordance with the terms of the Merger Agreement, (b) all of the issued and outstanding shares of Class A Common Stock held by the Company’s stockholders (other than Holdco) shall be converted into ordinary shares of Holdco at a one-for-one ratio, and (c) each outstanding warrant of the Company will be assumed by Holdco and automatically adjusted to become exercisable to purchase one ordinary share of Holdco (the “Proposed Business Combination”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Proposed Business Combination, the Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the Proposed Business Combination is not consummated, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<span id="xdx_909_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6RwLYLYAFnl" title="Intangible assets net">5,000,001</span> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will have until 15 months (subject to a three-month extension of time, as set forth in the Company’s registration statement) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem <span id="xdx_90C_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220101__20221231_zVTZ3sYhRTCl" title="Redemption percentage">100</span>% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit of $<span id="xdx_90C_ecustom--SharePriceAvailableForDistributionForPublicOfferingPricePerUnit_iI_c20221231_zEmDqMIHQEY9" title="Share price available for distribution for public offering price per unit">10.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--ProposedPublicOfferingMember_zIQ8awoiJaoe" title="Shares issued, price per share">10.15</span> per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity and Capital Resources</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had $<span id="xdx_90A_eus-gaap--Cash_iI_c20221231_zKM6IpLdpZv4" title="Cash in operating bank">27,066</span> of cash in its operating bank account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220101__20221231__srt--TitleOfIndividualAxis__custom--SponsorMember_zTA7f8DPEPR4" title="Proceeds from sale of units, net of IPO costs">25,000</span> from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the Sponsor of $<span id="xdx_903_eus-gaap--DueFromOfficersOrStockholders_iI_c20221231_z86uDhNkqQcc" title="Due from Officers or Stockholders">190,478</span> under the Note (as defined in Note 5). Following the IPO of the Company on January 24, 2022 (as described in Note 1), a total of $<span id="xdx_906_eus-gaap--ProceedsFromRepaymentsOfDebt_c20220123__20220124_zIFnHAax8Dh" title="Proceeds from (Repayments of) Debt">193,535</span> under the promissory note was repaid on January 24, 2022. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022, there was $<span id="xdx_90F_ecustom--WorkingCapitalLoan_iI_c20221231_zj6S8e0CuvAk" title="Working capital loan">100,000</span> outstanding under any Working Capital Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1125000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	11250000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	506250	usd
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	337500	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	87543750	usd
CY2022Q4	us-gaap	Cash Cash	27066	usd
CY2022Q4	DUET	Working Capital WorkingCapital	190081	usd
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2022Q4	DUET	Share Price Available For Distribution For Public Offering Price Per Unit SharePriceAvailableForDistributionForPublicOfferingPricePerUnit	10.00
CY2022Q4	us-gaap	Cash Cash	27066	usd
CY2022Q4	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	190478	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	193535	usd
CY2022Q4	DUET	Working Capital Loan WorkingCapitalLoan	100000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zGkK8fOdaoDe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zonHhiy09ZXi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	9101	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	229101	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zdAzS7lwNsYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zSGTk8s6O9C7">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zPRvAhIeEFW3" title="Cash, FDIC insured amount">250,000</span>. On December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.4pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2156250	shares
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2022Q4	DUET	Lenders Discretion LendersDiscretion	1500000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2022Q4	DUET	Working Capital Loan WorkingCapitalLoan	100000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
CY2022	DUET	Underwriting Discount Percentage UnderwritingDiscountPercentage	0.015	pure
CY2022	DUET	Deferred Underwriting Fee Percentage DeferredUnderwritingFeePercentage	0.030	pure
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares

Files In Submission

Name	View Source	Status
0001493152-23-010120-index-headers.html	Edgar Link	pending
0001493152-23-010120-index.html	Edgar Link	pending
0001493152-23-010120.txt	Edgar Link	pending
0001493152-23-010120-xbrl.zip	Edgar Link	pending
audit_001.jpg	Edgar Link	pending
audit_002.jpg	Edgar Link	pending
duet-20221231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
duet-20221231_def.xml	Edgar Link	unprocessable
duet-20221231_cal.xml	Edgar Link	unprocessable
duet-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
duet-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DUET
DUET Acquisition Corp Stock $duet

2022 Q4 Form 10-K Financial Statement

#000149315223010120 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET DUET Acquisition Corp Stock $duet

2022 Q4 Form 10-K Financial Statement

#000149315223010120 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET
DUET Acquisition Corp Stock $duet